Global Topical Corticosteroids Market 2023-2027

Description

List of Tables

The topical corticosteroids market is forecasted to grow by USD 1,089.66 mn during 2022-2027, accelerating at a CAGR of 4% during the forecast period. The report on the topical corticosteroids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in drug delivery systems, the growing aging population, and the rising prevalence of skin disorders.

Technavio's topical corticosteroids market is segmented as below:

By End-user

Hospitals
Dermatology clinics
Pharmacies
Others

By Type

Prescription
OTC

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing adoption of generic drugs as one of the prime reasons driving the topical corticosteroids market growth during the next few years. Also, the development of novel formulations and growing demand for natural and organic products will lead to sizable demand in the market.

The report on the topical corticosteroids market covers the following areas:

Topical corticosteroids market sizing
Topical corticosteroids market forecast
Topical corticosteroids market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading topical corticosteroids market vendors that include AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Galderma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., LEO Pharma AS, Merck and Co. Inc., Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the topical corticosteroids market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75330

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global topical corticosteroids market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global topical corticosteroids market 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
6.4 Dermatology clinics - Market size and forecast 2022-2027
Exhibit 38: Chart on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Dermatology clinics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Dermatology clinics - Year-over-year growth 2022-2027 (%)
6.5 Pharmacies - Market size and forecast 2022-2027
Exhibit 42: Chart on Pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by End-user
Exhibit 50: Market opportunity by End-user ($ million)
Exhibit 51: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 52: Chart on Type - Market share 2022-2027 (%)
Exhibit 53: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 54: Chart on Comparison by Type
Exhibit 55: Data Table on Comparison by Type
7.3 Prescription - Market size and forecast 2022-2027
Exhibit 56: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Prescription - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
7.4 OTC - Market size and forecast 2022-2027
Exhibit 60: Chart on OTC - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on OTC - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on OTC - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on OTC - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 64: Market opportunity by Type ($ million)
Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Russia - Market size and forecast 2022-2027
Exhibit 91: Chart on Russia - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Russia - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Russia - Year-over-year growth 2022-2027 (%)
9.9 Saudi Arabia - Market size and forecast 2022-2027
Exhibit 95: Chart on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Saudi Arabia - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Saudi Arabia - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Astellas Pharma Inc.
Exhibit 119: Astellas Pharma Inc. - Overview
Exhibit 120: Astellas Pharma Inc. - Product / Service
Exhibit 121: Astellas Pharma Inc. - Key news
Exhibit 122: Astellas Pharma Inc. - Key offerings
12.5 AstraZeneca PLC
Exhibit 123: AstraZeneca PLC - Overview
Exhibit 124: AstraZeneca PLC - Product / Service
Exhibit 125: AstraZeneca PLC - Key news
Exhibit 126: AstraZeneca PLC - Key offerings
12.6 Bausch Health Co. Inc.
Exhibit 127: Bausch Health Co. Inc. - Overview
Exhibit 128: Bausch Health Co. Inc. - Business segments
Exhibit 129: Bausch Health Co. Inc. - Key news
Exhibit 130: Bausch Health Co. Inc. - Key offerings
Exhibit 131: Bausch Health Co. Inc. - Segment focus
12.7 Bayer AG
Exhibit 132: Bayer AG - Overview
Exhibit 133: Bayer AG - Business segments
Exhibit 134: Bayer AG - Key news
Exhibit 135: Bayer AG - Key offerings
Exhibit 136: Bayer AG - Segment focus
12.8 Eli Lilly and Co.
Exhibit 137: Eli Lilly and Co. - Overview
Exhibit 138: Eli Lilly and Co. - Product / Service
Exhibit 139: Eli Lilly and Co. - Key news
Exhibit 140: Eli Lilly and Co. - Key offerings
12.9 Galderma SA
Exhibit 141: Galderma SA - Overview
Exhibit 142: Galderma SA - Product / Service
Exhibit 143: Galderma SA - Key news
Exhibit 144: Galderma SA - Key offerings
12.10 GlaxoSmithKline Plc
Exhibit 145: GlaxoSmithKline Plc - Overview
Exhibit 146: GlaxoSmithKline Plc - Business segments
Exhibit 147: GlaxoSmithKline Plc - Key news
Exhibit 148: GlaxoSmithKline Plc - Key offerings
Exhibit 149: GlaxoSmithKline Plc - Segment focus
12.11 Glenmark Pharmaceuticals Ltd.
Exhibit 150: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 151: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 152: Glenmark Pharmaceuticals Ltd. - Key offerings
12.12 LEO Pharma AS
Exhibit 153: LEO Pharma AS - Overview
Exhibit 154: LEO Pharma AS - Business segments
Exhibit 155: LEO Pharma AS - Key offerings
Exhibit 156: LEO Pharma AS - Segment focus
12.13 Merck and Co. Inc.
Exhibit 157: Merck and Co. Inc. - Overview
Exhibit 158: Merck and Co. Inc. - Business segments
Exhibit 159: Merck and Co. Inc. - Key news
Exhibit 160: Merck and Co. Inc. - Key offerings
Exhibit 161: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 162: Novartis AG - Overview
Exhibit 163: Novartis AG - Business segments
Exhibit 164: Novartis AG - Key offerings
Exhibit 165: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 166: Pfizer Inc. - Overview
Exhibit 167: Pfizer Inc. - Product / Service
Exhibit 168: Pfizer Inc. - Key news
Exhibit 169: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 170: Sanofi SA - Overview
Exhibit 171: Sanofi SA - Business segments
Exhibit 172: Sanofi SA - Key news
Exhibit 173: Sanofi SA - Key offerings
Exhibit 174: Sanofi SA - Segment focus
12.17 Viatris Inc.
Exhibit 175: Viatris Inc. - Overview
Exhibit 176: Viatris Inc. - Business segments
Exhibit 177: Viatris Inc. - Key news
Exhibit 178: Viatris Inc. - Key offerings
Exhibit 179: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 180: Inclusions checklist
Exhibit 181: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 182: Currency conversion rates for US$
13.4 Research methodology
Exhibit 183: Research methodology
Exhibit 184: Validation techniques employed for market sizing
Exhibit 185: Information sources
13.5 List of abbreviations
Exhibit 186: List of abbreviations